These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20530806)

  • 1. Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial.
    Lau JH; Gangji AS; Rabbat CG; Brimble KS
    Nephrol Dial Transplant; 2010 Dec; 25(12):4002-9. PubMed ID: 20530806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.
    Fort J; Cuevas X; García F; Pérez-García R; Lladós F; Lozano J; Martín-Malo A;
    Nephrol Dial Transplant; 2010 Aug; 25(8):2702-10. PubMed ID: 20176608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It's time to compare anemia management strategies in hemodialysis.
    Coyne DW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients.
    Sturm G; Lamina C; Zitt E; Lhotta K; Lins F; Freistätter O; Neyer U; Kronenberg F
    Nephrol Dial Transplant; 2010 Aug; 25(8):2715-22. PubMed ID: 20190241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes.
    Levin A; Djurdjev O; Duncan J; Rosenbaum D; Werb R
    Nephrol Dial Transplant; 2006 Feb; 21(2):370-7. PubMed ID: 16249203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV; Gagnon DR; Fink J; Seliger S; Fonda J; Do TP; Gaziano JM; Bradbury BD
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
    Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 12x/month haemoglobin monitoring with a computer algorithm reduces haemoglobin variability.
    Ho WR; Germain MJ; Garb J; Picard S; Mackie MK; Bartlett C; Will EJ
    Nephrol Dial Transplant; 2010 Aug; 25(8):2710-4. PubMed ID: 20176613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin level variability in renal transplant patients treated with erythropoiesis stimulating agents.
    Fernández Fresnedo G; de Francisco AL; Ruiz JC; Gómez Alamillo C; Arias M
    Transplant Proc; 2008 Nov; 40(9):2919-21. PubMed ID: 19010147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Lacson E; Ofsthun N; Lazarus JM
    Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
    Ferrari P; Mallon D; Trinder D; Olynyk JK
    Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
    Singh A
    Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
    Szczech LA; Bregman DB; Harrington RA; Morris D; Butcher A; Koch TA; Goodnough LT; Wolf M; Onken JE
    Nephrol Dial Transplant; 2010 Jul; 25(7):2368-75. PubMed ID: 20466657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?
    Gabutti L; Lötscher N; Bianda J; Marone C; Mombelli G; Burnier M
    BMC Nephrol; 2006 Sep; 7():13. PubMed ID: 16981983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.